Thiogenesis Proposes Phase 2 Trial to Evaluate Its NASH Treatment

MT NewswiresAug 20 11:02 ET

Thiogenesis Announces Collaboration and Updates on Pediatric NASH Clinical Program

newsfileAug 20 09:00 ET

Thiogenesis Announces Leigh Syndrome Clinical Program

newsfileJul 18 09:00 ET

Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS

newsfileMar 25 09:00 ET

Thiogenesis Therapeutics Completes Non-Brokered Private Placement

MT NewswiresDec 18, 2023 13:54 ET

Thiogenesis CEO Invited to Lead a Round Table Discussion at Influential Mitochondria Symposium

newsfileDec 4, 2023 09:00 ET